AstraZeneca Announces Plans to Acquire Fusion
The acquisition will bolster AstraZeneca’s ability to develop radioconjugates for cancer treatments.
October 24, 2026
The acquisition will bolster AstraZeneca’s ability to develop radioconjugates for cancer treatments.